1. Albano, C., Felberbaum, R.E., Smitz, J. et al. on behalf of the European Cetrorelix Study Group (2000) Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum. Reprod., 15, 526–531.
2. Barbieri, R.L. and Friedman, A.J. (eds) (1991) Gonadotropin Releasing Hormone Analogues. Elsevier, New York, pp. 1–15.
3. Ben Arie, A., Weissman, A. and Shoham, Z. (1996) Debate: Triggering the final stage of ovulation using gonadotrophin releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase. Hum. Reprod., 11, 1146–1148.
4. Brinsden, P.R., Wada, I., Tan, S.L. et al. (1995) Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br. J. Obstet. Gynaecol., 102, 767–772.
5. Caspi, E., Ron-El, R., Golan, A. et al. (1989) Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog d-Trip-6-luteinizing hormone-releasing hormone and gonadotropins. Fertil. Steril., 51, 95–99.